DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Worth Peripherals Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·10 Oct 2026, 11:43 am

WORTH NSE

Worth Peripherals Limited has submitted a certificate to the stock exchanges, confirming its compliance with SEBI (Depositories and Participants) Regulations, 2018. This filing is a standard regulatory requirement that companies must fulfill to maintain their listing status and ensure transparency in their dealings with depositories.

For investors, this news is largely procedural and does not indicate any operational or financial issues. The company is simply following the necessary legal framework to govern its shareholding and dematerialization processes. It serves as a routine update that keeps the company's regulatory filings current.

Investors should continue to focus on the company's core business performance and quarterly results. This filing is a routine administrative step and does not change the fundamental outlook of the stock. No immediate action is required from shareholders based on this update.